209 related articles for article (PubMed ID: 8046498)
1. Planar gamma camera imaging and quantitation of yttrium-90 bremsstrahlung.
Shen S; DeNardo GL; Yuan A; DeNardo DA; DeNardo SJ
J Nucl Med; 1994 Aug; 35(8):1381-9. PubMed ID: 8046498
[TBL] [Abstract][Full Text] [Related]
2. Bremsstrahlung radiation dose in yttrium-90 therapy applications.
Stabin MG; Eckerman KF; Ryman JC; Williams LE
J Nucl Med; 1994 Aug; 35(8):1377-80. PubMed ID: 8046497
[TBL] [Abstract][Full Text] [Related]
3. Collimator and energy window optimization for ⁹⁰Y bremsstrahlung SPECT imaging: A SIMIND Monte Carlo study.
Roshan HR; Mahmoudian B; Gharepapagh E; Azarm A; Pirayesh Islamian J
Appl Radiat Isot; 2016 Feb; 108():124-128. PubMed ID: 26720261
[TBL] [Abstract][Full Text] [Related]
4. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
[TBL] [Abstract][Full Text] [Related]
5. Quantitative bremsstrahlung imaging of yttrium-90 using a Wiener filter.
Shen S; DeNardo GL; DeNardo SJ
Med Phys; 1994 Sep; 21(9):1409-17. PubMed ID: 7838052
[TBL] [Abstract][Full Text] [Related]
6. Radiation dosimetry for 90Y-2IT-BAD-Lym-1 extrapolated from pharmacokinetics using 111In-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma.
DeNardo GL; O'Donnell RT; Shen S; Kroger LA; Yuan A; Meares CF; Kukis DL; DeNardo SJ
J Nucl Med; 2000 May; 41(5):952-8. PubMed ID: 10809213
[TBL] [Abstract][Full Text] [Related]
7. Energy-based scatter corrections for scintillation camera images of iodine-131.
Pollard KR; Lewellen TK; Kaplan MS; Haynor DR; Miyaoka RS; Eary JF; Durack LD
J Nucl Med; 1996 Dec; 37(12):2030-7. PubMed ID: 8970529
[TBL] [Abstract][Full Text] [Related]
8. Fast simulation of yttrium-90 bremsstrahlung photons with GATE.
Rault E; Staelens S; Van Holen R; De Beenhouwer J; Vandenberghe S
Med Phys; 2010 Jun; 37(6):2943-50. PubMed ID: 20632606
[TBL] [Abstract][Full Text] [Related]
9. A collimator optimization method for quantitative imaging: application to Y-90 bremsstrahlung SPECT.
Rong X; Frey EC
Med Phys; 2013 Aug; 40(8):082504. PubMed ID: 23927349
[TBL] [Abstract][Full Text] [Related]
10. Evaluation the effect of different collimators and energy window on Y-90 bremsstrahlung SPECT imaging by SIMIND Monte Carlo program.
Taherparvar P; Shahmari N
Nucl Med Rev Cent East Eur; 2019; 22(2):45-55. PubMed ID: 31482556
[TBL] [Abstract][Full Text] [Related]
11. A method for patient-specific absorbed dose estimation for internal beta emitters.
Williams LE; Liu A; Raubitschek AA; Wong JY
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3015s-3019s. PubMed ID: 10541337
[TBL] [Abstract][Full Text] [Related]
12. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
Seo Y; Wong KH; Sun M; Franc BL; Hawkins RA; Hasegawa BH
J Nucl Med; 2005 May; 46(5):868-77. PubMed ID: 15872362
[TBL] [Abstract][Full Text] [Related]
13. New knowledge about the bremsstrahlung image of strontium-89 with the scintillation camera.
Narita H; Hirase K; Uchiyama M; Fukushi M
Ann Nucl Med; 2012 Aug; 26(7):603-7. PubMed ID: 22767009
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments.
Casey JL; Pedley RB; King DJ; Green AJ; Yarranton GT; Begent RH
Br J Cancer; 1999 Nov; 81(6):972-80. PubMed ID: 10576653
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of quantitative planar 90Y bremsstrahlung whole-body imaging.
Minarik D; Ljungberg M; Segars P; Gleisner KS
Phys Med Biol; 2009 Oct; 54(19):5873-83. PubMed ID: 19759410
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric evaluation of copper-64 in copper-67-2IT-BAT-Lym-1 for radioimmunotherapy.
Shen S; DeNardo GL; DeNardo SJ; Salako Q; Morris G; Banks D; Yuan A; DeNardo DA
J Nucl Med; 1996 Jan; 37(1):146-50. PubMed ID: 8543984
[TBL] [Abstract][Full Text] [Related]
17. Bremsstrahlung imaging using the gamma camera: factors affecting attenuation.
Clarke LP; Cullom SJ; Shaw R; Reece C; Penney BC; King MA; Silbiger M
J Nucl Med; 1992 Jan; 33(1):161-6. PubMed ID: 1730984
[TBL] [Abstract][Full Text] [Related]
18. Dosimetry in radionuclide therapies with 90Y-conjugates: the IEO experience.
Cremonesi M; Ferrari M; Chinol M; Bartolomei M; Stabin MG; Sacco E; Fiorenza M; Tosi G; Paganelli G
Q J Nucl Med; 2000 Dec; 44(4):325-32. PubMed ID: 11302260
[TBL] [Abstract][Full Text] [Related]
19. Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.
Behr TM; Sgouros G; Stabin MG; Béhé M; Angerstein C; Blumenthal RD; Apostolidis C; Molinet R; Sharkey RM; Koch L; Goldenberg DM; Becker W
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3031s-3043s. PubMed ID: 10541340
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trial.
DeNardo SJ; Kramer EL; O'Donnell RT; Richman CM; Salako QA; Shen S; Noz M; Glenn SD; Ceriani RL; DeNardo GL
J Nucl Med; 1997 Aug; 38(8):1180-5. PubMed ID: 9255145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
